For example, α-tubulin acetylation is reduced in brains with Huntington’s disease, and enhancement of acetylation improves the recruitment of dynein and kinesin-1 to microtubules and increases the flux of vesicles and subsequent release of brain-derived neurotrophic factor59. This evidence concerns the gene KIF5C and Huntington disease.